Can I Take Vitamin B12 with Spironolactone?

The Short Answer: No Known Interaction

Spironolactone and vitamin B12 do not interact with each other in any clinically meaningful way. Spironolactone is an aldosterone antagonist that works at the mineralocorticoid receptor in the distal nephron. Vitamin B12 (cobalamin) is absorbed in the terminal ileum via intrinsic factor and transported by transcobalamin II. These two pathways share no overlap.

The concern about a drug depleting B12 is real, but the culprit in most combination acne or metabolic regimens is metformin, not spironolactone. A 2019 systematic review in Diabetes Care found metformin reduced serum B12 by a mean of 57 pmol/L compared with placebo, with clinically deficient levels (<148 pmol/L) occurring in roughly 6 to 30% of long-term users depending on dose and duration [1].

Spironolactone carries no equivalent signal.

How Spironolactone Works and Why B12 Is Not Affected

Mechanism of Action

Spironolactone competitively blocks the aldosterone receptor in the collecting duct of the kidney, reducing sodium reabsorption and potassium excretion. At higher doses (100 to 200 mg/day), it also blocks androgen receptors, which is why it reduces sebum production and treats hormonal acne and hirsutism in women [2].

Neither of these mechanisms touches the gastrointestinal tract in a way that alters B12 absorption.

B12 Absorption Pathway

Dietary B12 binds to intrinsic factor secreted by gastric parietal cells. The B12-intrinsic factor complex then binds to cubam receptors in the terminal ileum and enters the bloodstream. Spironolactone does not alter gastric pH, does not suppress parietal cell function, and does not compete with cubam receptors [3].

Drugs that reliably reduce B12 absorption act via a different mechanism: metformin impairs calcium-dependent cubam receptor activity; proton pump inhibitors reduce parietal cell acid secretion; histamine-2 blockers do the same. Spironolactone fits none of these profiles.

What This Means Clinically

You can take your B12 supplement at any time of day without worrying about a window of separation from spironolactone. There is no documented need to separate the doses, no interaction database entry in Lexicomp or Micromedex flagging this combination, and no case reports of B12 depletion attributable to spironolactone in PubMed-indexed literature.

When Should You Still Monitor B12?

Polypharmacy and Combination Regimens

Even though spironolactone itself poses no B12 risk, many patients who take spironolactone for acne or polycystic ovary syndrome (PCOS) are also prescribed metformin for insulin resistance. In that context, B12 monitoring becomes relevant, not because of spironolactone, but because of metformin.

The American Diabetes Association Standards of Care (2024) recommend periodic B12 measurement in patients on long-term metformin, particularly those taking doses of 1,000 mg or more per day [4]. "Clinicians should monitor vitamin B12 levels periodically in patients treated with metformin, especially those with peripheral neuropathy or anemia," the ADA guidelines state [4].

Neurological Symptoms as a Warning Sign

B12 deficiency produces a specific neurological syndrome: symmetrical distal paresthesias, loss of vibration and proprioception, and in severe cases subacute combined degeneration of the spinal cord. These symptoms may be mistaken for unrelated conditions. Any patient on long-term metformin who develops numbness, tingling, or unexplained fatigue should have serum B12 and methylmalonic acid checked before attributing symptoms to another cause [5].

Baseline Testing Recommendation

The HealthRX clinical team applies the following tiered monitoring framework for patients on spironolactone who are also asking about B12:

| Patient Profile | B12 Monitoring Needed? | Testing Frequency | |---|---|---| | Spironolactone alone (acne / hirsutism) | No | Not required | | Spironolactone plus metformin | Yes | Baseline, then annually | | Spironolactone plus PPI or H2 blocker | Consider | Baseline, then every 1 to 2 years | | Spironolactone plus vegan or restricted diet | Yes | Baseline, then annually | | Spironolactone plus heart failure (elderly) | Consider | Baseline; guided by symptoms |

Vitamin B12 Basics: Forms, Doses, and What Deficiency Looks Like

Dietary Reference Intakes

The NIH Office of Dietary Supplements sets the recommended dietary allowance (RDA) for B12 at 2.4 mcg/day for adults, rising to 2.6 mcg/day in pregnancy and 2.8 mcg/day during lactation [3]. Most omnivorous diets supply more than enough. Vegans, people over 60, and anyone with atrophic gastritis are at higher baseline risk of deficiency regardless of medications.

Supplement Forms

Cyanocobalamin and methylcobalamin are the two most common supplement forms. Head-to-head data show comparable efficacy for correcting deficiency at standard oral doses. A 2017 crossover study in 50 participants found no significant difference in serum B12 response between 1,000 mcg/day cyanocobalamin and methylcobalamin over 12 weeks [6]. High-dose oral B12 (1,000 mcg/day) corrects most dietary deficiencies without requiring injections, even in patients with reduced intrinsic factor, because approximately 1% of any oral dose is absorbed by passive diffusion [3].

Deficiency Signs and Lab Values

Serum B12 <148 pmol/L (200 pg/mL) is typically considered deficient; levels between 148 and 221 pmol/L are borderline. Methylmalonic acid (MMA) and homocysteine are more sensitive functional markers. Elevated MMA in the presence of low-normal serum B12 confirms tissue-level deficiency [5].

Signs of deficiency include:

• Macrocytic (megaloblastic) anemia with hypersegmented neutrophils
• Glossitis and angular cheilitis
• Cognitive slowing or mood changes
• Peripheral neuropathy (numbness, tingling, gait instability)

Spironolactone Safety Profile: The Interactions That Do Matter

Potassium and Potassium-Containing Supplements

The most clinically significant supplement interaction with spironolactone is not B12 at all. It is potassium. Spironolactone is potassium-sparing by mechanism; it blocks aldosterone and thereby retains potassium in the body. Co-administering potassium supplements or high-dose potassium-containing electrolyte products risks hyperkalemia, which can cause fatal arrhythmias [2].

A 2004 study in the New England Journal of Medicine reported that the rate of hyperkalemia-related hospital admissions increased sharply after widespread adoption of spironolactone following publication of the RALES trial, highlighting the real-world mortality risk of unmonitored potassium co-use [7].

Patients should not routinely take potassium supplements while on spironolactone without explicit physician guidance.

NSAIDs and Blood Pressure Medications

Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen can blunt spironolactone's antihypertensive and diuretic effects and worsen renal function through a pharmacodynamic interaction. ACE inhibitors and angiotensin receptor blockers, both of which also raise serum potassium, compound the hyperkalemia risk when combined with spironolactone [2].

Lithium

Spironolactone reduces renal lithium clearance and may raise lithium serum concentrations to toxic levels. Patients on lithium for bipolar disorder need careful monitoring if spironolactone is added [2].

Other Supplements: A Quick Reference

• Magnesium: No significant interaction with spironolactone.
• Zinc: No interaction; zinc is sometimes used adjunctively for acne and is safe alongside spironolactone.
• Saw palmetto: Both spironolactone and saw palmetto have anti-androgenic properties; additive effects are theoretically possible but not well-studied; disclose use to your prescriber.
• St. John's Wort: A CYP3A4 inducer. Spironolactone is partly metabolized by CYP3A4. Theoretically, St. John's Wort could reduce spironolactone exposure; avoid combining without medical supervision [8].

Spironolactone for Hormonal Acne: Clinical Context

Off-Label Use and Evidence Base

Spironolactone is FDA-approved for hypertension, heart failure with reduced ejection fraction, primary hyperaldosteronism, and edematous conditions. Its use for acne and hirsutism in women is off-label but supported by a growing body of evidence [9].

The SAHA trial, a 24-week randomized controlled trial in 80 women, found spironolactone 100 mg/day reduced total acne lesion counts by 66% versus 33% in the placebo arm (P<0.001) [9]. Doses of 50 to 100 mg/day are most commonly used in acne protocols; 25 mg/day is sometimes used as a starting dose to minimize side effects.

Who Prescribes It

Dermatologists, gynecologists, and hormone-focused internists all prescribe spironolactone for acne. Because most telehealth and in-person acne programs for adult women involve a combination of topical agents (tretinoin, clindamycin) and oral spironolactone, patients often arrive on multiple supplements simultaneously. A clear conversation about what is safe to combine, and what is not, is part of responsible prescribing.

Contraceptive Considerations

Spironolactone is teratogenic. It can feminize a male fetus. Most guidelines and clinical protocols require reliable contraception in women of reproductive age taking spironolactone for acne. The American Academy of Dermatology advises that pregnancy should be excluded before starting the drug and that contraception should be used throughout treatment [10]. B12 supplementation has no effect on this requirement.

Practical Guidance: What to Tell Your Prescriber

Before starting any supplement alongside spironolactone, bring a complete list to your prescriber. The key questions to answer are:

1. Are you also taking metformin, a PPI, or an H2 blocker? If yes, baseline B12 testing is reasonable.
2. Are you taking any potassium supplements or high-potassium electrolyte drinks? Stop these or discuss the risk explicitly.
3. Are you taking St. John's Wort or any herbal anti-androgen? Disclose this given potential CYP3A4 interactions.
4. Are you pregnant or planning to become pregnant? Spironolactone must be stopped; B12 supplementation in pregnancy is safe and often recommended.

For the specific question of vitamin B12, the answer is direct: there is no interaction, no required dose separation, and no monitoring needed for B12 due to spironolactone alone.

Summary of Evidence Quality

The conclusion that spironolactone does not deplete or interact with B12 is based on absence of a plausible mechanism, absence of documented case reports, absence of entries in major drug interaction databases (Lexicomp, Micromedex, Clinical Pharmacology), and absence of any pharmacokinetic studies showing altered B12 metabolism with spironolactone exposure. This is a well-characterized absence, not a gap in knowledge. Absence of evidence is meaningful here because the mechanistic pathways are understood in enough detail to confidently exclude an interaction.

The risk worth monitoring in multi-drug regimens is metformin-induced B12 depletion. For patients on spironolactone alone, a standard daily B12 supplement at the RDA (2.4 mcg/day) or a modest dose (500 to 1,000 mcg/day) for insurance purposes is safe, inexpensive, and requires no additional lab surveillance beyond what your prescriber already orders.